Anuh Pharma Limited (BOM:506260)
India flag India · Delayed Price · Currency is INR
82.12
-0.87 (-1.05%)
At close: Feb 12, 2026

Anuh Pharma Statistics

Total Valuation

Anuh Pharma has a market cap or net worth of INR 8.12 billion. The enterprise value is 7.99 billion.

Market Cap8.12B
Enterprise Value 7.99B

Important Dates

The last earnings date was Friday, February 6, 2026.

Earnings Date Feb 6, 2026
Ex-Dividend Date Aug 14, 2025

Share Statistics

Anuh Pharma has 100.22 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class 100.22M
Shares Outstanding 100.22M
Shares Change (YoY) -0.08%
Shares Change (QoQ) +0.22%
Owned by Insiders (%) 71.84%
Owned by Institutions (%) 0.00%
Float 27.92M

Valuation Ratios

The trailing PE ratio is 19.40.

PE Ratio 19.40
Forward PE n/a
PS Ratio 1.06
PB Ratio 2.48
P/TBV Ratio 2.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 19.10
EV / Sales 1.04
EV / EBITDA 13.76
EV / EBIT 16.20
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA 0.00
Debt / FCF n/a
Interest Coverage 123.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 11.72%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 6.17%
Revenue Per Employee 26.02M
Profits Per Employee 1.42M
Employee Count295
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Anuh Pharma has paid 141.60 million in taxes.

Income Tax 141.60M
Effective Tax Rate 25.29%

Stock Price Statistics

The stock price has decreased by -8.25% in the last 52 weeks. The beta is 0.34, so Anuh Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.34
52-Week Price Change -8.25%
50-Day Moving Average 77.81
200-Day Moving Average 88.55
Relative Strength Index (RSI) 60.21
Average Volume (20 Days) 4,714

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Anuh Pharma had revenue of INR 7.68 billion and earned 418.22 million in profits. Earnings per share was 4.17.

Revenue7.68B
Gross Profit 1.63B
Operating Income 492.89M
Pretax Income 559.82M
Net Income 418.22M
EBITDA 576.28M
EBIT 492.89M
Earnings Per Share (EPS) 4.17
Full Income Statement

Balance Sheet

The company has 130.96 million in cash and 2.27 million in debt, with a net cash position of 128.69 million or 1.28 per share.

Cash & Cash Equivalents 130.96M
Total Debt 2.27M
Net Cash 128.69M
Net Cash Per Share 1.28
Equity (Book Value) 3.27B
Book Value Per Share 32.64
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 21.29%, with operating and profit margins of 6.42% and 5.45%.

Gross Margin 21.29%
Operating Margin 6.42%
Pretax Margin 7.29%
Profit Margin 5.45%
EBITDA Margin 7.51%
EBIT Margin 6.42%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 0.91%.

Dividend Per Share 0.75
Dividend Yield 0.91%
Dividend Growth (YoY) 20.00%
Years of Dividend Growth 5
Payout Ratio n/a
Buyback Yield 0.08%
Shareholder Yield 0.98%
Earnings Yield 5.15%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 15, 2025. It was a forward split with a ratio of 2.

Last Split Date Jul 15, 2025
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score 1